z-logo
open-access-imgOpen Access
Brain-Derived Neurotrophic Factor Administration Mediated Oligodendrocyte Differentiation and Myelin Formation in Subcortical Ischemic Stroke
Author(s) -
Jaime RamosCejudo,
María GutiérrezFernández,
Laura OteroOrtega,
Berta RodríguezFrutos,
Blanca Fuentes,
María Teresa VallejoCremades,
Teresa Navarro Hernanz,
Sebastián Cerdán,
Exuperio Díez–Tejedor
Publication year - 2014
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.114.006692
Subject(s) - remyelination , oligodendrocyte , medicine , neurotrophic factors , white matter , myelin basic protein , brain derived neurotrophic factor , endocrinology , olig2 , myelin , vascular endothelial growth factor , neuroscience , receptor , central nervous system , magnetic resonance imaging , biology , radiology , vegf receptors
Translational research is beginning to reveal the importance of trophic factors as a therapy for cellular brain repair. The purpose of this study was to analyze whether brain-derived neurotrophic factor (BDNF) administration could mediate oligodendrogenesis and remyelination after white matter injury in subcortical stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom